Curtis & Coulter LLC, a new specialty life science events organizer is pleased to announce two new events specifically designed for pharmaceutical and biotech professionals. Taking place over the course of two days in November the events will be held at the Westin San Diego, CA.
The Bioequivalence: Intersection Between Science & Regulatory Summit and the Oral Drug Formulation Innovations Summit were created to assist the life science industry with a simplified, compliant path for future drug approval and to accelerate drug product time-to-market.
"Given today's current development challenges, there is a clear need for unified industrial collaboration in the fields of oral formulation development and bioequivalence testing." stated Simon Curtis, Co-Founder & CEO of Curtis & Coulter LLC. "We are thrilled that multiple major industry players and global regulatory agencies share this vision, and are joining us this November for the benefit of the wider industry". November's events will highlight key speakers from Pfizer, Merck, GlaxoSmithKline and Johnson & Johnson. Additionally presenters will include the FDA, and a number of other global regulatory agencies.
Registration is currently open for attendees for both November events. You can find out some more information by visiting www.curtiscoulter.com